Algorae Pharmaceuticals Ltd - Asset Resilience Ratio

Latest as of December 2025: 37.48%

Algorae Pharmaceuticals Ltd (1AI) has an Asset Resilience Ratio of 37.48% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Algorae Pharmaceuticals Ltd (1AI) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets

AU$750.00K

≈ $530.67K USD Cash + Short-term Investments

Total Assets

AU$2.00 Million

≈ $1.42 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Algorae Pharmaceuticals Ltd's Asset Resilience Ratio has changed over time. See Algorae Pharmaceuticals Ltd (1AI) shareholders funds for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Algorae Pharmaceuticals Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 1AI market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$0.00	0%
Short-term Investments	AU$750.00K	37.48%
Total Liquid Assets	AU$750.00K	37.48%

Asset Resilience Insights

Very High Liquidity: Algorae Pharmaceuticals Ltd maintains exceptional liquid asset reserves at 37.48% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Algorae Pharmaceuticals Ltd Industry Peers by Asset Resilience Ratio

Compare Algorae Pharmaceuticals Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	3.28%
Ascendis Pharma AS F:A71	Biotechnology	0.00%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Sinopep-Allsino Biopharmaceutical Co. Ltd. A SHG:688076	Biotechnology	1.39%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
R&G PharmaStudies Co. Ltd. A SHE:301333	Biotechnology	35.96%
Shanghai Shen Lian Biomedical Corp SHG:688098	Biotechnology	3.87%

Annual Asset Resilience Ratio for Algorae Pharmaceuticals Ltd (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Algorae Pharmaceuticals Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	77.13%	AU$1.85 Million ≈ $1.31 Million	AU$2.40 Million ≈ $1.70 Million	+35.26pp
2024-06-30	41.87%	AU$2.30 Million ≈ $1.63 Million	AU$5.49 Million ≈ $3.89 Million	--
2023-06-30	0.00%	AU$0.00 ≈ $0.00	AU$6.23 Million ≈ $4.41 Million	--
2022-06-30	0.00%	AU$0.00 ≈ $0.00	AU$4.27 Million ≈ $3.02 Million	--
2021-06-30	2.64%	AU$43.30K ≈ $30.64K	AU$1.64 Million ≈ $1.16 Million	-86.07pp
2020-06-30	88.71%	AU$3.01 Million ≈ $2.13 Million	AU$3.39 Million ≈ $2.40 Million	+3.50pp
2019-06-30	85.21%	AU$4.91 Million ≈ $3.47 Million	AU$5.76 Million ≈ $4.08 Million	-4.97pp
2018-06-30	90.18%	AU$6.86 Million ≈ $4.86 Million	AU$7.61 Million ≈ $5.38 Million	+3.57pp
2017-06-30	86.61%	AU$7.53 Million ≈ $5.33 Million	AU$8.69 Million ≈ $6.15 Million	--
2016-06-30	0.00%	AU$0.00 ≈ $0.00	AU$6.31 Million ≈ $4.47 Million	--

pp = percentage points

About Algorae Pharmaceuticals Ltd

AU:1AI Australia Biotechnology

Market Cap

$20.04 Million

AU$28.32 Million AUD

Market Cap Rank

#25009 Global

#1085 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.02

All Time High

AU$0.25